Chen X, Fromm JR, Naresh KN. “Blasts” in myeloid neoplasms – how will we outline blasts and the way will we incorporate them into diagnostic schema shifting ahead? Leukemia. 2022;36:327–32.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189–99.
Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001 351.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: Worldwide Company for Analysis on Most cancers; 2008. 439.
Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. Worldwide scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88.
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised worldwide prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–65.
Bernard E, Nannya Y, Hasserjian RP, Devlin SM, Tuechler H, Medina-Martinez JS, et al. Implications of TP53 allelic state for genome stability, medical presentation and outcomes in myelodysplastic syndromes. Nat Med. 2020;26:1549–56.
Malcovati L, Stevenson Okay, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J, et al. SF3B1-mutant MDS as a definite illness subtype: a proposal from the Worldwide Working Group for the Prognosis of MDS. Blood. 2020;136:157–70.
Bernard E, Tuechler H, Greenberg PL, Hasserjian RP, Arango Ossa JE, Nannya Y, et al. Molecular worldwide prognostic scoring system for myelodysplastic syndromes. NEJM Evid. 2022;1:EVIDoa2200008.
Huber S, Haferlach T, Müller H, Meggendorfer M, Hutter S, Hoermann G, et al. MDS subclassification—will we nonetheless should depend blasts? Leukemia. 2023;37:942–5.
Estey E, Hasserjian RP, Döhner H. Distinguishing AML from MDS: a hard and fast blast proportion could not be optimum. Blood. 2022;139:323–32.
Hodes A, Calvo KR, Dulau A, Maric I, Solar J, Braylan R. The difficult job of enumerating blasts within the bone marrow. Semin Hematol. 2019;56:58–64.
Saft L, Timar B, Porwit A. Enumeration of CD34+ blasts by immunohistochemistry in bone marrow biopsies from MDS sufferers could have vital influence on last WHO classification. J Hematopathol. 2020;13:79–88.
